OVIDNasdaqPharmaceutical Preparations

Ovid Therapeutics Inc. (OVID) earnings date, market-implied expected move, and options open interest by expiry

2.82

Closed16:40 ET

Open2.44Volume3.6MMkt cap$535.1M

Day2.39 – 2.82100%52-wk1.18 – 3.1185%

OVID

Ovid Therapeutics Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 10

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

—

Linked news

5dLGND · customerLigand posts Q3 net loss of $28,485 thousand, nine-month income of $6,678 thousand
6dTAK · customerTakeda: six-month revenue JPY 2,407.0 billion; net profit JPY 305,716 million

News

Largest filed tie

13F top-10 QoQ

+45.90%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

131 managers

Top fund weight

0.12%

OVID weight · XBI

N-PORTJun 30 '26

4 funds

Ovid Therapeutics (OVID) is expected to report on Nov 10 before open (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

OI · 3 expiries · Nov 3 close

1.54OI · 3 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1310%Nov 2015d850%

44+13%Jan 1571d0.014,811+1%0.01

209+111%Apr 16162d0.141,454+1112%0.14

ExpiryPutsCallsP/C

Nov 2015d1310%850%1.54

Jan 1571d44+13%4,811+1%0.01

Apr 16162d209+111%1,454+1112%0.14

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−2047.61%as filednet margin · revenue −88.31% YoY

Revenue$733,000—

Gross profit$733,000100.00%—

Operating income−$16M−2141.61%+12.04%

Pre-tax income−$15M+11.65%

Net income−$15M−2047.61%+11.65%

Cost of revenue$0—

Operating expenses$16M−7.93%

Tax$0—

Other income$689,000−19.70%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:30 ET

Intraday

Event sensitivity

PCE ×1.33· ±5.0% vs ±3.7% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±5.0%7 of 19×1.33

CPROFcorporate profits±4.1%7 of 12×1.11

PPIproducer prices±3.9%5 of 10×1.03

CPIconsumer prices±3.8%5 of 10×1.03

GDPgross domestic product±3.6%8 of 19×0.96

FOMCrate decision±3.4%12 of 24×0.90

NFPjobs report±2.0%4 of 10×0.54

Bar = avg |move| to ±5% · tick = ±3.7% avg day · ×base = |move| ÷ ±3.7% · min 6 releases

Earnings history

EPS -0.08 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-0.08	—
Q1 FY26	—	-0.12	—
Q3 FY25	—	-168.18	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod